NDUFA11 and cervical cancer: Overexpression of AKR1C2 is found to be a mildly favorable prognostic marker (Supplementary Table 12) but lower expression of NADH:ubiquinone oxidoreductase subunit A11 (NDUFA11) is prognostically unfavorable in cervical cancer (Supplementary Table 12).